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Abstract 
 
The pericarp of mangosteen (Garcinia mangostana L.) is rich in various xanthones that are 
known to possess unique biological activities. The aim of this study was to determine of anti-
proliferative and cytotoxic activities of mangosteen xanthones.  The researchers found that all 
tested xanthones inhibited the growth of the cancer cells. They observed cytotoxic properties 
against three human cancer cell lines, epidermoid carcinoma of the mouth, breast cancer, and 
small-cell lung cancer. The specific xanthones include alpha-mangostins, showed that man-
gosteen xanthones not only inhibit the proliferation of target cells but also induce their death 
by apoptosis that involves the activation of the caspase cascade. To establish a more precise 
mechanism of action, a cell free biochemical kinase assay against multiple cyclins/CDKs in-
volved in cell cycle progression; the most significant inhibition in the cell free based assays 
was CDK4, a critical component of the G1 phase.Through molecular modeling α-mangostin 
against the ATP binding pocket of CDK4, and propose three possible orientations that may 
result in CDK4 inhibition. Histopathological evaluation and biochemical analysis of tumors 
that received mangosteen xanthones indicate the induction of apoptosis in tumors, which re-
sulted in the repression of their growth and the reduction of their sizes. The study concluded 
that mangosteen xanthones potentially as an agent for cancer prevention and the combination 
therapy with anti-cancer drugs. 
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Abstrak 
 
Kulit buah manggis (Garcinia mangostana L.) diketahui banyak mengandung senyawa xan-
thones yang mempunyai beragam aktivitas biologi yang bermanfaat. Tujuan dari penulisan ini 
adalah mengulas tentang aktivitas sitotoksik dan anti-proliferatif xanthones mangosteen, teru-
tama dalam menghambat pertumbuhan sel cancer. Beberapa peneliti mengobservasi sitotoksi-
sitas human cancer cell lines, yaitu: epidermoid carcinoma rongga mulut, kanker payudara 
dan kanker paru. Hasilnya menunjukkan bahwa dalam alphamangostins tidak hanya meng-
hambat proliferasi sel target namun juga menginduksi kematian sel melalui apoptosis, yang 
melibatkan aktivasi caspase cascade. Untuk mengetahui meknisme kerjanya, metode a cell 
free biochemical kinase assay terhadap multiple cyclins/CDKs yang terlibat dalam progresi 
siklus sel. Proses inhibisi yang paling signifikan dalam cell free based assays adalah CDK4, 
dimana merupakan komponen penting (critical component) pada fase G1. Melalui mekanisme 
molekular α-mangostin pada ATP yang berikatan dengan pocket CDK4, akan menghasilkan 3 
kemungkinan orientasi yang akan menyebabkan inhibisi CDK4.  Pada evaluasi histopatholog-
ical dan analisis biokimia dari jaringan tumor diketahui bahwa xanthone mngosteen dapat 
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menginduksi apoptosis pada tumor, dengan adanya penekanan pertumbuhan dan penurunan 
ukuran dari jaringan tumor.  Dari hasil review dapat disimpulkan bahwa xanthone mangosteen 
berpotensi sebagai agen pencegahan terhadap kanker dan sebagai terapi kombinasi bersamaan 
dengan obat-obatan anti kanker. 
 
Kata kunci: xanthones, kulit buah manggis, anti-kanker, apoptosis 
 
Introduction 
 
Oral cancer is one of the 10 most 
frequently occurring cancers world-wide. 
The 5-year survival rate of less than 50% has 
not substantially improved over the past 
several decades, since many oral carcinomas 
respond poorly to chemotherapy approaches 
and their responses to radiation therapy have 
been highly variable. 1,2 
Oral squamous cell carcinoma is a type 
of cancer, that usually develops on the 
squamous or epithelial cells, that cover the 
lips and the oral cavity. The malignant or 
cancerous cells are usually found on the floor 
of the mouth or on the surface of the tongue. 
These cancerous cells also originate on the 
lower lips and palate or the tonsillar area of 
the oral cavity. The squamous cell carcinoma 
is believed to develop from the keratinizing 
or malpighian epithelial cells, as the presence 
of keratin has been observed in the malignant 
cells. It is one of the most prevalent types of 
oral and pharyngeal cancers. 3 
The pericarp of mangosteen (Garcinia 
mangostana L.) is rich in various xanthones 
that are known to possess unique biological 
activities. The researchers found that all 
tested xanthones inhibited the growth of the 
cancer cells. They observed cytotoxic 
properties against three human cancer cell 
lines, epidermoid carcinoma of the mouth, 
breast cancer, and small-cell lung cancer. 
The specific xanthones include alphama 
ngostins, showed that mangosteen xanthones 
not only inhibit the proliferation of target 
cells but also induce their death by apoptosis 
that involves the activation of the caspase 
cascade.4  
Some research for anti cancer agents 
from plant sources, all the polyphenols and 
terpenoids tested which exhibited an anti-
proliferative effect, were observed to induce 
apoptosis by targeting mitochondria with a 
decreased membrane potential, leading to the 
activation of the intrinsic apoptotic signal 
transduction. In some cases, the early res-
ponsive signaling cascades including protein 
kinases MAPK and Akt referring to growth 
and survival, respectively, were down 
regulated.  reports indicated a potent anti-
proliferative activity of 4 xanthones (α-
mangostin, β-mangostin, γ-mangostin, and 
methoxy β-mangostin) from the pericarps of 
mangosteen against human leukemia HL60 
cells. Interestingly, α-mangostin was obser-
ved to induce mitochondrial dysfunction. 
Moreover, it induced cell-cycle arrest and 
apop-tosis in human colon cancer DLD-1 
cells.5  In this review, we discuss the mecha 
nism of anti-cancer effect of xanthones and 
the potentiality of chemopreventive agents 
for oral cancer. 
 
Mangosteen Xanthones 
 
The mangosteen (Garcinia Mangostana) 
is a tropical fruit considered to be one of the 
finest tasting fruits in the world and has 
earned the popular title "the Queen of Fruit." 
The mangosteen tree is found predominantly 
in Southeast Asia in countries like Cambodia, 
China, Indonesia, Malaysia, Singapore, Tai-
wan and Thailand. 
Xanthones are a class of plant derived 
nutrients or "phytonutrients." They have been 
demonstrated in numerous scientific studies 
to hold tremendous nutritional value.  Found 
to exhibit strong antioxidant activity xan-
thones disarm free radicals in the body and 
enhance and support your body's immune 
system. Although xanthones exist in small 
amounts throughout nature, it is found in 
concentrated amounts in the Pericarp of the 
mangosteen fruit. 5 
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Figure 1. The Garcinia mangostana Linn tree (A), the appearance of mangosteen fruit 
(B) and the chemical structures of xanthones included in the pericarps (C) 
 
There are over 20 known forms of 
xanthones naturally occurring in the Pericarp, 
the two most widely studied are Alpha 
Mangostin and Gamma Mangostin. Accor 
ding to the research, the most concentrated 
source of xanthones found in nature is in the 
Pericarp (rind) of the mangosteen fruit. The 
majority of clinical studies on xanthones 
specify that the xanthones used were from 
the mangosteen Pericarp. Phytochemical 
studies have shown that they contain a 
variety of secondary metabolites, such as 
oxygenated and prenylated xanthones. 
Recent studies revealed that these xanthones 
exhibited a variety of biological activities 
containing anti-inflammatory, anti-bacterial, 
and anti-cancer effects.7 
 
Oral Squamous Cell Carcinoma 
 
Oral squamous cell carcinoma is a type 
of cancer, that usually develops on the 
squamous or epithelial cells, that cover the 
lips and the oral cavity. The malignant or 
cancerous cells are usually found on the floor 
of the mouth or on the surface of the tongue. 
These cancerous cells also originate on the 
lower lips and palate or the tonsillar area of 
the oral cavity. The squamous cell carcinoma 
is believed to develop from the keratinizing 
or malpighian epithelial cells, as the presence 
of keratin has been observed in the malignant 
cells. It is one of the most prevalent types of 
oral and pharyngeal cancers. 
The most important risk factors of oral 
squamous cell carcinoma are tobacco smok-
ing and alcohol consumption. Many studies 
have shown that smoking and excessive in-
take of alcohol are the leading causes of this 
disease. More than 90% of the people af-
fected by this disease have been found to 
smoke and/or drink alcohol. In addition, 
squamous cell carcinoma of the tongue may 
be caused by chronic dental caries, chewing 
tobacco and betel quid. Besides this, oral 
human papilloma virus (HPV) can also be 
responsible for causing oral squamous cell 
carcinoma. 
The common symptom of oral squamous 
cell carcinoma is the appearance of scaly or 
ulcerated plaque or lesions in the oral cavity. 
Sometimes, a red patch of lesions, known as 
erythroplakia, can be observed. Appearance 
of leukoplakia, a patch of white tissue on the 
mucous membrane of the mouth is also very 
common. Besides these, a sore on the lips or 
gums, a lump on the lips or the gums, a white 
or red patch on the gum, tongue and tonsils 
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and swelling of the jaw are some other symp-
toms of this cancer. A sore throat can also be 
a symptom of squamous cell carcinoma of 
the tonsils. 
Oral lesions or ulcers are usually de-
tected during a physical examination of the 
lips and oral cavity. But all these lesions and 
plaque are not necessarily malignant or can-
cerous, which necessitates further tests, to 
ensure a proper diagnosis of the disease. One 
of the most important tests, is a biopsy of the 
affected area. In addition to this, laryngosco-
py, bronchoscopy and esophagoscopy are 
also carried out to detect and exclude cancers 
of the larynx, bronchial tubes and esophagus. 
In addition to these, chest X-ray and CT scan 
of the head, chest and neck are performed to 
properly diagnose the stages of the disease. 
The commonly used treatment options 
for oral squamous cell carcinoma are surgery 
and radiation therapy. Surgery is usually car-
ried out in the early stage of the disease. 
Sometimes, chemotherapy is used, particular-
ly if the disease spreads to other areas like 
the lungs, bones, pericardium and heart. 
Squamous cell carcinoma of the lips and ton-
gue are treated by surgically removing the 
affected area. However, surgical reconstruc-
tion of lips is required to enable individuals 
to carry out normal oral activities. 
Oral squamous cell carcinoma can sig-
nificantly increase the risk of both head and 
neck cancer, accounting for almost 90% of 
all head and neck cancers. Almost 30,000 
people are affected each year by this disease 
in the United States. As it has been observed 
that this cancer largely affects those individ-
uals who indulge in excessive smoking and 
alcohol consumption, so controlling these 
risk factors can play a significant role in pre-
venting the occurrence and reducing the se-
verity of the disease3. 
 
Mechanism apoptosis of squamous cell 
carcinoma 
 
The apoptotic potential of cancer cells in 
correlation to their proliferative dynamics 
profoundly affects malignant phenotypes, 
and it appears that pathways governing cell 
proliferation and cell death are intercon-
nected. Failure to enter apoptosis allows 
transformed cells to enter further cell divi-
sions and acquire further mutations. In the 
present review, we focus on genetic altera-
tions of caspases and their regulators, under-
lining the role of these molecules in cancer 
development. 
 Deregulation of caspase expression 
and/or activity could be a result of various 
factors, including genetic alterations, promo-
ter methylation, alternative splicing and post-
translational modifications. We show exam-
ples that different mutation could have pro-
found effects on caspases activity. Caspase-3 
mutation was investigated in squamous cell 
carcinoma of the head and neck (SCCHN). 
8,9,10 
The majority of currently available anti-
cancer drugs act at least in part through in-
duction of apoptosis, therefore, a defect in 
the apoptotic propensity of tumours affects 
their response to treatment. As described 
above, a number of anticancer therapies are 
being tested that influence the expression 
and/or activity of factors that regulate apop-
tosis. Targeting caspases and apoptotic ma-
chinery will play an increasingly important 
role in future modern cancer therapy, and 
approaches are being developed that allow 
“on demand” activation of expression. This 
will be achieved using siRNA technology, 
the small molecule inhibitors, as well as pep-
tides and peptidomimetics. These approaches 
may eventually replace the traditional chemo 
and radiation therapies, and result in more 
efficient cancer treatments that are devoid of 
side effects.11 
 
Mechanism of α-Mangostin-inducing 
Apoptosis 
 
In our previous study, it was demonstrat-
ed that α-mangostin activated caspase-9 and -
3 but not -8 in HL60 cells, indicating that α-
mangostin may mediate the mitochondrial 
pathway in the apoptotic process. Parameters 
of mitochondrial dysfunctions such as swel-
ling, loss of membrane potential, decrease in 
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intracellular ATP, ROS accumulation, and 
cytochrome c/AIF release, Matsumoto was 
observed within 1 or 2 h after the treatment, 
indicating that α-mangostin preferentially 
targets mitochondria in the early phase. Inte-
restingly, replacement of hydroxyl group by 
methoxy group remarkably decreased the po-
tency to cause mitochondrial dysfunction. It 
was also shown that the cytotoxicity was cor-
related with the decrease in the mitochondrial 
membrane potential. Furthermore, we dem-
onstrated that α-mangostin induced a cell 
cycle arrest at G1/S and the subsequent apop-
tosis via the intrinsic pathway in DLD-1 
cells, while a cell cycle arrest by γ-mangostin 
was at S phase. The changes in expression of 
cell cycle regulatory proteins were shown in. 
α-Mangostin induced apoptosis was mediated 
by a caspase independent pathway via mito-
chondria with the release of Endo-G, a 
known 30-kD nuclease residing in mitochon-
dria, is able to induce nucleosomal DNA 
fragmentation. 12,13 
 
 
 
 
Figure 2. Schematic diagram shows the possible effect of xanthones on the apoptosis 
pathways. Xanthones induce apoptosis occurrence, preferentially activate the 
mitochondrial pathway, support intracellular ATP decrease, cytochrome c/AIF release, 
caspase-9 and caspase-3 activation, endonuclease-G release. Furthermore, xanthones 
also influence cancer cells apoptosis via miR-143/ERK5/c-Myc pathway, NO inhibition, 
cell-cycle arrest, sarcoendoplasmic reticulum Ca2+-ATPase inhibition, and intracellular 
ROS accumulation.14 
 
Mitogen activated protein kinases (MAPKs) 
and Akt kinase are key regulatory proteins in 
cells. MAPKs are a widely conserved family 
of serine/threonine protein kinases involved 
in many cellular processes such as cell proli-
feration, differentiation, motility, and death. 
Akt, another serine / threonine protein ki-
nase, is associated with cell survival, growth, 
and glycogen metabolism. Various phyto-
chemicals have been shown to modulate the 
signaling pathways of MAPKs and/or Akt, 
leading to growth inhibition and cell death. 
Erk1/2 may play a dual role, acting first 
as a cellular adaptive response at the initial 
phase and then as a cytotoxic response at the 
later stage. As reported, the decline in p-
Erk1/2 after the later peak may be associated 
with the apoptotic machinery. On the other 
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hand, in the Akt signaling the level of p-Akt 
was markedly reduced at 6 h following α-
mangostin treatment, coincident with the 
occurrence of apoptosis. Therefore, down-
regulation of Akt signaling could participate 
in the mechanism of apoptosis induced by α-
mangostin. 15 
The cell cycle is normally regulated by a 
number of proteins, including p53, p21waf, 
the cyclin-dependent kinases (cdks) and their 
activators, the cyclins. The dysregu lation of 
cell cycle machinery and checkpoint 
signaling pathways is a hallmark of malig 
nant cells. Thus, modulation of cell cycle 
progression is one of the major strategies for 
both chemoprevention and chemotherapy. 
Treatment of mangosteen results in a 
direct inhibition of the proliferation and 
viability of various cancer cell types in vitro, 
as manifested by the significant arrest of cells 
at various phases of the cell cycle. by the 
inactivation of the signaling cascades 
involving Erk1/2 and Akt at 3 h-treatment. 
The cell cycle regulatory proteins cyclin D1 
and cdc2 were also down-regulated at 3 h 
treatment. 14,15 
 
 
 
 
 
Figure 3: An overview: how xanthones induce cell-cycle arrest. Xanthones block the cell 
cycle by activation or inhibition of cyclins, cdks, inhibitor of cdks, transcription factors 
or oncoproteins in cancer cells. 14 
 
 
Discussion 
 
Apoptotic cell death is controlled by 
proapoptotic caspases, proteases that are 
synthesized as inactive precursors and 
activated by proteolytic processing . The 
apoptotic cascade can be initiated via two 
major pathways, involving either the release 
of cytochrome C from the mitochondria 
(mitochondrial pathway) or activation of 
death receptors in response to ligand binding 
(death receptor pathway). Upon triggering of 
either pathway, caspases, the final 
executioners of apoptosis, are activated, 
causing degradation of cellular proteins and 
leading to typical morphological changes 
such as chromatin conden sation, nuclear 
shrinkage, and the formation of apoptotic 
bodies. Both pathways are differentially 
involved in the cellular response to diverse 
apoptotic stimuli. The majority of 
chemotherapeutic agents trigger the 
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mitochondrial pathway, but the death 
receptors have also been reported to be in-
volved in chemotherapy-induced apoptosis. 
11 
Death ligands such as TNF-α or CD95L 
recruit, via the adapter molecule FADD, 
cytoplasmic mono-meric initiator caspase-8 
to their sur-face receptors, resulting in dime-
ri-zation and activation of caspase-8. Active 
caspase-8 cleaves and activates downstream 
effector caspases including caspase-3, -6 or -
7, which degrade a broad range of cellular 
proteins and trigger the appearance of the 
apoptotic morphology . On the other hand, 
mitochondria are important regulatory sites 
of the apoptotic process. Defects in 
mitochondrial function result in release of 
cytochrome C, which can associate with 
Apaf-1 (apoptosis protease activating factor) 
and procaspase-9. The observation that 
chemical inhibition of caspase-9 blocks 
hypoxiainduced apoptosis points to a role of 
the complex in hypoxia-induced apoptosis. 
This activation complex results in auto-
processing of caspase-9 and further 
activation of down-stream caspases, such as 
caspase-3. Activation of caspase-3 has been 
linked to the proteolytic cleavage of cellular 
substrates including poly-ADP-ribose-
polymerase (PARP), and is also necessary for 
the nuclear changes and chromatin 
condensation associated with apoptosis. 12 
The anti-proliferative effects of the 
xanthones were associated with cell-cycle 
arrest by affecting the expression of cyclins, 
cdc2, and p27; G1 arrest by α-mangostin and 
β-Mangostin, and S arrest by γ-mangostin. α-
Mangostin found to induce apoptosis through 
the activation of intrinsic pathway following 
the downregulation of signaling cascades 
involving MAP kinases and the 
serine/threonine kinase Akt. 
 
Conclusions  
 
New strategies for cancer treatment are 
being developed, and one of the most prom-
ising treatment strategies involves the appli-
cation of chemopreventive agents. The 
search for novel and effective cancer chemo-
preventive agents has led to the identification 
of various naturally occurring compounds. 
The potential chemopreventive and chemo-
therapeutic activities of xanthones have been 
demonstrated in different stages of carcino-
genesis (initiation, promotion, and progres-
sion) and are known to control cell division 
and growth, apoptosis, inflammation, and 
metastasis. Carcinogenesis prevention is con-
sidered to be a promising alternative strategy 
for the treatment of cancer. Based on this in-
formation, this review presents compelling 
evidence for the use of mangosteen not only 
to prevent but also to treat cancer due to the 
similar molecular targets that affect tumor 
initiation, promotion, and progression. Taken 
together, these results support that mangos-
teen can modulate various molecular path-
ways involved in multiple processes of carci-
nogenesis including the inactivation of carci-
nogens, the induction of apoptosis, the initia-
tion of cell cycle arrest, and the suppression 
of metastasis. Although there is compelling 
evidence to suggest that xanthones from 
mangosteen may be a remarkable candidate 
for chemopreventive and chemotherapeutic 
strategies due to its efficacy and pharmaco-
logical safety, further research must be con-
ducted before the compounds can be em-
ployed as an agent for the chemopreven-
tion/treatment of cancer. 
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